Linking lipids to chromatin

Current Opinion in Genetics and Development

Volumn 14, Issue 2, 2004, Pages 196-202

  Jones, David R ^a   Divecha, Nullin ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

ACF; ATP dependent chromatin assembly factor; ING2; Inhibitor of growth protein 2; NHEJ; Non homologous end joining; Nucleosome remodelling factor; NURF; PHD; Phosphoinositide; PI; Plant homedomain

Indexed keywords

DNA; GROWTH FACTOR; LIPID; NUCLEAR PROTEIN; PHOSPHATIDYLINOSITIDE;

APOPTOSIS; CELL CYCLE; CELL DIFFERENTIATION; CELL NUCLEUS; CHROMATIN; CHROMATIN STRUCTURE; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; GENETIC REGULATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION; REVIEW; SECOND MESSENGER; STIMULUS; STIMULUS RESPONSE; YEAST;

CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; HUMANS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHATIDYLINOSITOLS; SIGNAL TRANSDUCTION; YEASTS;

EID: 1942503402     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2004.02.003     Document Type: Review

References (63)

1. Peterson C.L. Chromatin remodeling: nucleosomes bulging at the seams. Curr Biol. 12:2002;R245-R247.
2. Turner B.M. Cellular memory and the histone code. Cell. 111:2002;285-291.
3. Agalioti T., Chen G., Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell. 111:2002;381-392.
4. Payrastre B., Missy K., Giuriato S., Bodin S., Plantavid M., Gratacap M. Phosphoinositides: key players in cell signalling, in time and space. Cell Signal. 13:2001;377-387.
5. De Camilli P., Emr S.D., McPherson P.S., Novick P. Phosphoinositides as regulators in membrane traffic. Science. 271:1996;1533-1539.
6. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13:1999;2905-2927.
7. Ellson C.D., Andrews S., Stephens L.R., Hawkins P.T. The PX domain: a new phosphoinositide-binding module. J Cell Sci. 115:2002;1099-1105.
8. Dowler S., Currie R.A., Campbell D.G., Deak M., Kular G., Downes C.P., Alessi D.R. Identification of pleckstrin-homology-domain-containing proteins with novel phosphoinositide-binding specificities. Biochem J. 351:2000;19-31.
9. De Camilli P., Chen H., Hyman J., Panepucci E., Bateman A., Brunger A.T. The ENTH domain. FEBS Lett. 513:2002;11-18.
10. Gaullier J.M., Simonsen A., D'Arrigo A., Bremnes B., Stenmark H., Aasland R. FYVE fingers bind PtdIns(3)P. Nature. 394:1998;432-433.
11. Xu Y., Seet L.F., Hanson B., Hong W. The Phox homology (PX) domain, a new player in phosphoinositide signalling. Biochem J. 360:2001;513-530.
12. Yin H.L., Janmey P.A. Phosphoinositide regulation of the actin cytoskeleton. Annu Rev Physiol. 65:2003;761-789.
13. Smith C.D., Wells W.W. Phosphorylation of rat liver nuclear envelopes. II. Characterization of in vitro lipid phosphorylation. J Biol Chem. 258:1983;9368-9373.
14. Cocco L., Gilmour R.S., Ognibene A., Letcher A.J., Manzoli F.A., Irvine R.F. Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation. Biochem J. 248:1987;765-770.
15. Capitani S., Bertagnolo V., Mazzoni M., Santi P., Previati M., Antonucci A., Manzoli F.A. Lipid phosphorylation in isolated rat liver nuclei. Synthesis of polyphosphoinositides at subnuclear level. FEBS Lett. 254:1989;194-198.
16. Payrastre B., Nievers M., Boonstra J., Breton M., Verkleij A.J., Van Bergen en Henegouwen P.M. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. J Biol Chem. 267:1992;5078-5084.
17. Vann L.R., Wooding F.B., Irvine R.F., Divecha N. Metabolism and possible compartmentalization of inositol lipids in isolated rat-liver nuclei. Biochem J. 327:1997;569-576.
18. Osborne S.L., Thomas C.L., Gschmeissner S., Schiavo G. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. J Cell Sci. 114:2001;2501-2511.
19. Yokogawa T., Nagata S., Nishio Y., Tsutsumi T., Ihara S., Shirai R., Morita K., Umeda M., Shirai Y., Saitoh N., Fukui Y. Evidence that 3′-phosphorylated polyphosphoinositides are generated at the nuclear surface: use of immunostaining technique with monoclonal antibodies specific for PI 3,4-P(2). FEBS Lett. 473:2000;222-226.
20. Watt S.A., Kular G., Fleming I.N., Downes C.P., Lucocq J.M. Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. Biochem J. 363:2002;657-666.
21. Boronenkov I.V., Loijens J.C., Umeda M., Anderson R.A. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell. 9:1998;3547-3560.
22. Ozaki S., DeWald D.B., Shope J.C., Chen J., Prestwich G.D. Intracellular delivery of phosphoinositides and inositol phosphates using polyamine carriers. Proc Natl Acad Sci USA. 97:2000;11286-11291.
23. Hunt A.N., Clark G.T., Attard G.S., Postle A.D. Highly saturated endonuclear phosphatidylcholine is synthesized in situ and colocated with CDP-choline pathway enzymes. J Biol Chem. 276:2001;8492-8499.
24. Xu A., Suh P.G., Marmy-Conus N., Pearson R.B., Seok O.Y., Cocco L., Gilmour R.S. Phosphorylation of nuclear phospholipase C beta1 by extracellular signal-regulated kinase mediates the mitogenic action of insulin-like growth factor I. Mol Cell Biol. 21:2001;2981-2990.
25. Xu A., Wang Y., Xu L.Y., Gilmour R.S. Protein kinase C alpha -mediated negative feedback regulation is responsible for the termination of insulin-like growth factor I-induced activation of nuclear phospholipase C beta1 in Swiss 3T3 cells. J Biol Chem. 276:2001;14980-14986.
26. Divecha N., Letcher A.J., Banfic H.H., Rhee S.G., Irvine R.F. Changes in the components of a nuclear inositide cycle during differentiation in murine erythroleukaemia cells. Biochem J. 312:1995;63-67.
27. Martelli A.M., Cataldi A., Manzoli L., Billi A.M., Rubbini S., Gilmour R.S., Cocco L. Inositides in nuclei of Friend cells: changes of polyphosphoinositide and diacylglycerol levels accompany cell differentiation. Cell Signal. 7:1995;53-56.
28. Faenza I., Matteucci A., Bavelloni A., Marmiroli S., Martelli A.M., Gilmour R.S., Suh P.G., Manzoli L., Cocco L. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. Biochim Biophys Acta. 1589:2002;305-310.
29. Clarke J.H., Letcher A.J., D'Santos C.S., Halstead J.R., Irvine R.F., Divecha N. Inositol lipids are regulated during cell cycle progression in the nuclei of murine erythroleukaemia cells. Biochem J. 357:2001;905-910.
30. Capitani S., Cocco L., Maraldi N.M., Papa S., Manzoli F.A. Effect of phospholipids on transcription and ribonucleoprotein processing in isolated nuclei. Adv Enzyme Regul. 25:1986;425-438.
31. Kuvichkin V.V. DNA-lipid interactions in vitro and in vivo. Bioelectrochemistry. 58:2002;3-12.
32. Yu H., Fukami K., Watanabe Y., Ozaki C., Takenawa T. Phosphatidylinositol 4,5-bisphosphate reverses the inhibition of RNA transcription caused by histone H1. Eur J Biochem. 251:1998;281-287.
33. Zhao K., Wang W., Rando O.J., Xue Y., Swiderek K., Kuo A., Crabtree G.R. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell. 95:1998;625-636.
34. Eisen J.A., Sweder K.S., Hanawalt P.C. Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res. 23:1995;2715-2723.
35. Shen X., Ranallo R., Choi E., Wu C. Involvement of actin-related proteins in ATP-dependent chromatin remodeling. Mol Cell. 12:2003;147-155 The authors use yeast genetics to demonstrate a role both in vivo and in vitro for the actin-related subunits in regulating chromatin-remodeling complexes.
36. Bourachot B., Yaniv M., Muchardt C. The activity of mammalian brm/SNF2alpha is dependent on a high-mobility-group protein I/Y-like DNA binding domain. Mol Cell Biol. 19:1999;3931-3939.
37. 2.
38. Memedula S., Belmont A.S. Sequential recruitment of HAT and SWI/SNF components to condensed chromatin by VP16. Curr Biol. 13:2003;241-246 This paper uses in vivo imaging techniques to demonstrate that transcriptional activation leads to the sequential recruitment of factors involved in regulating chromatin structure. The authors suggest that the recruitment to the promoter of the key ATPase of chromatin remodeling complexes may increase chromatin accessibility before the subsequent recruitment of other components of the complex.
39. 2.
40. York J.D., Odom A.R., Murphy R., Ives E.B., Wente S.R. A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science. 285:1999;96-100.
41. Odom A.R., Stahlberg A., Wente S.R., York J.D. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science. 287:2000;2026-2029.
42. 5 in yeast. Mutants within the gene encoding the protein give rise to strains that have impaired remodelling of the PHO5 promoter and the ATP-dependent chromatin-remodelling complexes SWI/SNF and INO80 are not efficiently recruited to phosphate-responsive promoters.
43. 6 are important for gene transcription in yeast.
44. Shears S.B. Transcriptional regulation: a new dominion for inositol phosphate signaling? Bioessays. 22:2000;786-789.
45. Nalaskowski M.M., Deschermeier C., Fanick W., Mayr G.W. The human homologue of yeast ArgRIII protein is an inositol phosphate multikinase with predominantly nuclear localization. Biochem J. 366:2002;549-556.
46. Hanakahi L.A., Bartlet-Jones M., Chappell C., Pappin D., West S.C. Binding of inositol phosphate to DNA-PK and stimulation of double- strand break repair. Cell. 102:2000;721-729.
47. Ma Y., Lieber M.R. Binding of inositol hexakisphosphate (IP6) to Ku but not to DNA-PKcs. J Biol Chem. 277:2002;10756-10759.
48. Gaillard H., Fitzgerald D.J., Smith C.L., Peterson C.L., Richmond T.J., Thoma F. Chromatin remodeling activities act on UV-damaged nucleosomes and modulate DNA damage accessibility to photolyase. J Biol Chem. 278:2003;17655-17663.
49. Frit P., Kwon K., Coin F., Auriol J., Dubaele S., Salles B., Egly J.M. Transcriptional activators stimulate DNA repair. Mol Cell. 10:2002;1391-1401.
50. D'Santos C.S., Clarke J.H., Divecha N. Phospholipid signalling in the nucleus. Een DAG uit het leven van de inositide signalering in de nucleus. Biochim Biophys Acta. 1436:1998;201-232.
51. Doughman R.L., Firestone A.J., Anderson R.A. Phosphatidylinositol phosphate kinases put PI4,5P(2) in its place. J Membr Biol. 194:2003;77-89.
52. Visnjic D., Curic J., Crljen V., Batinic D., Volinia S., Banfic H. Nuclear phosphoinositide 3-kinase C2beta activation during G2/M phase of the cell cycle in HL-60 cells. Biochim Biophys Acta. 1631:2003;61-71.
53. Visnjic D., Crljen V., Curic J., Batinic D., Volinia S., Banfic H. The activation of nuclear phosphoinositide 3-kinase C2beta in all-trans-retinoic acid-differentiated HL-60 cells. FEBS Lett. 529:2002;268-274.
54. Capili A.D., Schultz D.C., Rauscher F.J. III, Borden K.L. Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J. 20:2001;165-177.
55. Pascual J., Martinez-Yamout M., Dyson H.J., Wright P.E. Structure of the PHD zinc finger from human Williams-Beuren syndrome transcription factor. J Mol Biol. 304:2000;723-729.
56. Heino M., Peterson P., Kudoh J., Shimizu N., Antonarakis S.E., Scott H.S., Krohn K. APECED mutations in the autoimmune regulator (AIRE) gene. Hum Mutat. 18:2001;205-211.
57. Vogel A., Strassburg C.P., Obermayer-Straub P., Brabant G., Manns M.P. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med. 80:2002;201-211.
58. Gibbons R.J., Picketts D.J., Villard L., Higgs D.R. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome). Cell. 80:1995;837-845.
59. Gibbons R.J., Bachoo S., Picketts D.J., Aftimos S., Asenbauer B., Bergoffen J., Berry S.A., Dahl N., Fryer A., Keppler K.et al. Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet. 17:1997;146-148.
60. Gozani O., Karuman P., Jones D.R., Ivanov D., Cha J., Lugovskoy A.A., Baird C.L., Zhu H., Field S.J., Lessnick S.L.et al. The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell. 114:2003;99-111 This paper describes phosphoinositide (predominantly PtdIns[5]P) binding to the PHD finger motif found within the putative tumour suppressor protein ING2. PtdIns(5)P binding in vivo is essential for ING2 function during p53-dependent apoptosis. This paper provides the first link between PtdInsPs and processes that regulate responses to DNA damage.
61. Feng X., Hara Y., Riabowol K. Different HATS of the ING1 gene family. Trends Cell Biol. 12:2002;532-538.
62. Andrulis E.D., Neiman A.M., Zappulla D.C., Sternglanz R. Perinuclear localization of chromatin facilitates transcriptional silencing. Nature. 394:1998;592-595.
63. Feuerbach F., Galy V., Trelles-Sticken E., Fromont-Racine M., Jacquier A., Gilson E., Olivo-Marin J.C., Scherthan H., Nehrbass U. Nuclear architecture and spatial positioning help establish transcriptional states of telomeres in yeast. Nat Cell Biol. 4:2002;214-221.